Pinnbrook Capital Management LP Invests $2.01 Million in Waters Corporation $WAT

Pinnbrook Capital Management LP purchased a new position in shares of Waters Corporation (NYSE:WAT) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 5,360 shares of the medical instruments supplier’s stock, valued at approximately $2,010,000.

Other hedge funds have also added to or reduced their stakes in the company. Anchor Investment Management LLC acquired a new position in shares of Waters during the 1st quarter worth $27,000. Resources Management Corp CT ADV acquired a new stake in Waters in the first quarter valued at about $27,000. Zions Bancorporation National Association UT grew its position in Waters by 121.2% in the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 40 shares during the last quarter. Vision Retirement LLC bought a new position in Waters in the first quarter valued at about $29,000. Finally, Bollard Group LLC acquired a new position in Waters during the first quarter worth about $29,000. 94.01% of the stock is owned by institutional investors.

Waters Stock Performance

NYSE:WAT opened at $412.37 on Friday. The company has a market capitalization of $40.52 billion, a PE ratio of 102.84, a P/E/G ratio of 2.39 and a beta of 1.19. The company has a 50 day simple moving average of $381.79 and a two-hundred day simple moving average of $347.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. Waters Corporation has a fifty-two week low of $282.77 and a fifty-two week high of $421.74.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.01 by $0.04. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.62 billion. Waters had a net margin of 3.58% and a return on equity of 11.27%. The company’s revenue was up 113.3% compared to the same quarter last year. During the same quarter last year, the business earned $2.95 EPS. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Research analysts anticipate that Waters Corporation will post 14.57 earnings per share for the current year.

Insider Buying and Selling at Waters

In related news, Director Christopher A. Kuebler sold 3,626 shares of Waters stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the transaction, the director owned 17,808 shares of the company’s stock, valued at $7,086,515.52. This trade represents a 16.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.31% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on WAT shares. Barclays increased their target price on shares of Waters from $425.00 to $460.00 and gave the stock an “overweight” rating in a report on Wednesday, August 5th. Sanford C. Bernstein initiated coverage on shares of Waters in a research note on Friday, June 26th. They issued an “outperform” rating and a $435.00 price objective for the company. Stifel Nicolaus set a $420.00 target price on shares of Waters in a research report on Wednesday, August 5th. Morgan Stanley set a $430.00 target price on shares of Waters in a research note on Wednesday, August 5th. Finally, The Goldman Sachs Group increased their price target on Waters from $380.00 to $425.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Three investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $420.35.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.